Trofeit Lisa, Sattler Elisabeth, Künz Johannes, Hilbert Friederike
Institute of Food Safety, University of Veterinary Medicine, 1210 Vienna, Austria.
Antibiotics (Basel). 2023 Mar 16;12(3):595. doi: 10.3390/antibiotics12030595.
subsp. is a zoonotic bacterial pathogen that causes foodborne outbreaks in humans. Lytic bacteriophages to control in food production are already being used in scientific studies and some are commercially available. However, phage application is still controversial. In addition to virulent phages, which are used in phage therapy and lyse the bacterial host, lysogenic phages coexist in the environment and can reside as prophages in the bacterial host. Therefore, information about prophages is essential to understand successful phage therapy. In 100 food isolates of the serovars Enteritidis and Typhimurium, we propagated prophages by oxidative stress. In isolates of the serovars Typhimurium and Enteritidis, 80% and 8% prophages could be activated, respectively. In the phage lysates from the serovar Typhimurium, the following antibiotic resistance genes or gene fragments were detected by PCR: , , , and ; however, no ,,, , , , , or were detected. In contrast, no resistance genes were amplified in the phage lysates of the serovar Enteritidis. None of the phage lysates was able to transduce phenotypic resistance to WT 14028s. Most of the prophage lysates isolated were able to infect the various serovars tested. The high abundance of prophages in the genome of the serovar Typhimurium may counteract phage therapy through phage resistance and the development of hybrid phages.
亚种是一种人畜共患的细菌病原体,可导致人类食源性疾病暴发。用于控制食品生产中该病菌的裂解性噬菌体已在科学研究中使用,有些已商业化。然而,噬菌体的应用仍存在争议。除了用于噬菌体疗法并裂解细菌宿主的烈性噬菌体外,溶原性噬菌体也存在于环境中,并可作为原噬菌体存在于细菌宿主中。因此,有关该病菌原噬菌体的信息对于理解成功的噬菌体疗法至关重要。在100株肠炎沙门氏菌和鼠伤寒沙门氏菌血清型的食品分离株中,我们通过氧化应激增殖原噬菌体。在鼠伤寒沙门氏菌和肠炎沙门氏菌血清型的分离株中,分别有80%和8%的原噬菌体可以被激活。在鼠伤寒沙门氏菌血清型的噬菌体裂解物中,通过PCR检测到以下抗生素抗性基因或基因片段:……;然而,未检测到……。相比之下,肠炎沙门氏菌血清型的噬菌体裂解物中未扩增出抗性基因。没有一种噬菌体裂解物能够将表型抗性转导至野生型14028s。分离出的大多数原噬菌体裂解物能够感染所测试的各种该病菌血清型。鼠伤寒沙门氏菌血清型基因组中原噬菌体的高丰度可能通过噬菌体抗性和杂交噬菌体的产生来对抗噬菌体疗法。